Partially covered SEMS
DeviceBoston Scientific, Natick, United States diameter 18 mm, lengths of 10, 12 and 15 cm available
Other names: WallFlex Partially covered esophageal stent
NCT Number: NCT01661686
The purpose of this study is to determine whether fully covered or partially covered metal stents are more favorable in incurable malignant stenosis of the esophagus or cardia. Primary outcome will be the occurence of recurrent dysphagia which is defined as dysphagia due to a stent or tumour related cause in a 6-month follow-up
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
IJsselland Hospital, Capelle aan den IJssel, South Holland, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Boston Scientific, Natick, United States diameter 18 mm, lengths of 10, 12 and 15 cm available
Other names: WallFlex Partially covered esophageal stent
Boston Scientific, Natick, United States diameter 18 mm, lengths of 10, 12 and 15 cm available
Other names: WallFlex Fully covered esophageal stent
Time frame: From stent placement (t=0) until death or placement of second stent, assessed up to 6 months.
This is defined as occurrence of dysphagia due to a stent or tumor related cause. These include tumor in- or overgrowth, stent migration, stent fracture or food impaction.
Time frame: At stent placement (t=0)
Technical succes was defined as succesful deployment of the stent which bridges the stricture
Time frame: From stent placement until death or placement of second stent, assessed up to 6 months.
Clinical success was defined as an improvement of dysphagia (at least 1 point reduction in the Dysphagia score) during follow-up.
Dysphagia scores will be obtained at time point: t=0, t= 1 week, t=2 weeks, t=1 month, t=3 months and t= 6 months
Time frame: From stent placement until death or placement of second stent, assessed up to 6 months
A major adverse event was defined as a life-threatening event, including perforation, major haemorrhage, severe pain (NRS pain score ≥ 7), pneumonia, stridor and fistula.
Time frame: From stent placement until death or placement of second stent
Survival from stent placement until death or placement of second stent
Foundation for Liver Research
Other
A Randomized Comparison of a Fully Covered Self Expandable Metal Stent Versus a Partially Covered Self Expandable Metal Stent in Malignant Esophageal Strictures
Acronym: COPAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00183898
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT00341276
Digestive System Diseases, Digestive System Neoplasms
Taiyuan, China
View Trial DetailsNCT00342654
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT05538195
Colon Cancer, Colonic Diseases
Henan, China
View Trial Details